Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan
· Delayed Price · Currency is TWD 31.80
+0.10 (0.32%)
Apr 29, 2026, 1:30 PM CST
Taiyen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,360 | 6,340 | 6,490 | 6,840 | 6,490 | 6,640 | Upgrade
|
| Market Cap Growth | -1.09% | -2.31% | -5.12% | 5.39% | -2.26% | 1.53% | Upgrade
|
| Enterprise Value | 4,740 | 4,800 | 4,991 | 5,405 | 4,866 | 5,217 | Upgrade
|
| Last Close Price | 31.80 | 31.70 | 31.19 | 31.72 | 28.80 | 28.18 | Upgrade
|
| PE Ratio | 15.98 | 15.86 | 17.47 | 22.77 | 15.21 | 16.89 | Upgrade
|
| PS Ratio | 1.92 | 1.92 | 2.00 | 2.01 | 1.80 | 1.62 | Upgrade
|
| PB Ratio | 0.93 | 0.93 | 0.97 | 1.04 | 0.97 | 1.02 | Upgrade
|
| P/TBV Ratio | 0.93 | 0.93 | 0.98 | 1.06 | 1.00 | 1.05 | Upgrade
|
| P/FCF Ratio | 48.22 | 48.07 | 18.41 | 60.59 | 19.40 | 31.43 | Upgrade
|
| P/OCF Ratio | 14.72 | 14.67 | 9.83 | 15.05 | 11.18 | 11.07 | Upgrade
|
| EV/Sales Ratio | 1.43 | 1.45 | 1.54 | 1.59 | 1.35 | 1.27 | Upgrade
|
| EV/EBITDA Ratio | 6.59 | 6.76 | 8.89 | 10.62 | 7.74 | 7.37 | Upgrade
|
| EV/EBIT Ratio | 10.00 | 10.12 | 14.08 | 16.81 | 10.93 | 9.86 | Upgrade
|
| EV/FCF Ratio | 35.94 | 36.39 | 14.16 | 47.88 | 14.54 | 24.69 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.17 | 0.17 | 0.36 | 0.42 | 0.21 | 0.55 | Upgrade
|
| Debt / FCF Ratio | 0.95 | 0.95 | 0.58 | 1.95 | 0.41 | 1.86 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.24 | -0.26 | -0.25 | -0.26 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.28 | -2.28 | -3.08 | -3.18 | -2.78 | -2.38 | Upgrade
|
| Net Debt / FCF Ratio | -12.28 | -12.28 | -4.91 | -14.34 | -5.22 | -7.99 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.39 | 0.41 | 0.43 | 0.50 | Upgrade
|
| Inventory Turnover | 4.89 | 4.89 | 4.67 | 5.36 | 5.83 | 7.66 | Upgrade
|
| Quick Ratio | 2.38 | 2.38 | 2.10 | 2.29 | 2.77 | 2.18 | Upgrade
|
| Current Ratio | 2.87 | 2.87 | 2.51 | 2.75 | 3.34 | 2.60 | Upgrade
|
| Return on Equity (ROE) | 5.84% | 5.84% | 4.80% | 3.29% | 6.49% | 6.40% | Upgrade
|
| Return on Assets (ROA) | 3.56% | 3.56% | 2.65% | 2.43% | 3.33% | 4.07% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.34% | 7.46% | 5.27% | 4.31% | 7.36% | 9.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.50% | 6.50% | 4.90% | 4.50% | 6.10% | 7.40% | Upgrade
|
| Earnings Yield | 6.29% | 6.31% | 5.73% | 4.39% | 6.58% | 5.92% | Upgrade
|
| FCF Yield | 2.07% | 2.08% | 5.43% | 1.65% | 5.16% | 3.18% | Upgrade
|
| Dividend Yield | 4.42% | 4.42% | 4.17% | 3.78% | 5.21% | 5.32% | Upgrade
|
| Payout Ratio | 65.02% | 65.02% | 64.60% | 99.87% | 70.31% | 68.66% | Upgrade
|
| Buyback Yield / Dilution | -0.04% | -0.04% | -0.06% | 0.08% | -0.05% | - | Upgrade
|
| Total Shareholder Return | 4.41% | 4.38% | 4.11% | 3.87% | 5.16% | 5.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.